IL-11

IL-11

IL-11 Overview

Molecule Name
Interleukin-11
Synonyms
IL-11,Interleukin-11,AGIF,Oprelvekin,IL11
Drug Development Progress
Drugs in Clinical Trials4
Approved Drugs1
Highest Development StageApproved
Target Synonym
Oprelvekin,IL-11,Interleukin 11,Adipogenesis inhibitory factor,AGIF
Background
Interleukin-11 (IL-11) is a pleiotropic cytokine that stimulates megakaryocytopoiesis, resulting in increased production of platelets, as well as activating osteoclasts, inhibiting epithelial cell proliferation and apoptosis, and inhibiting macrophage mediator production. These functions may be particularly important in mediating the hematopoietic, osseous and mucosal protective effects of IL-11. The cytokine also possesses anti-inflammatory activity, and has been proposed as a therapeutic agent in the treatment of chronic inflammatory diseases, such as Crohn's disease and rheumatoid arthritis. Although IL-11 was initially believed to be restricted to mammals, subsequent studies demonstrated it to be expressed in fish. Despite close similarity in gene structure and conservation of key amino acids between fish and mammalian IL-11, they share relatively low overall amino acid identity and may not necessarily be functionally analogous.

IL-11 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
9MW38119MW3811Phase 2 ClinicalMabwell (Shanghai) Bioscience Co Ltd
Cicatrix; Fibrosis; Idiopathic Pulmonary Fibrosis; Neoplasms; Pulmonary Fibrosis; Solid tumours
Details
BI-765423BI-765423; BI765423Phase 2 ClinicalBoehringer Ingelheim Ltd
Idiopathic Pulmonary Fibrosis
Details
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co Ltd
Asthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive
Details
LASN-03Lassen Therapeutics
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )ApprovedHangzhou Jiuyuan Gene Biomedical Co Ltd
Thrombocytopenia
Details